New Results
Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: a randomized, single-blind, crossover study
View ORCID ProfileMuhidin K Mahende, Eric Huber, Elly Kourany-Lefoll, Ali Ali, View ORCID ProfileBrooke Hayward, Deon Bezuidenhout, Wilhelmina Bagchus, Abdunoor M Kabanywanyi, On behalf of the Pediatric Praziquantel Consortium
doi: https://doi.org/10.1101/605170
Muhidin K Mahende
1Ifakara Health Institute, Dar es Salaam, Tanzania
Eric Huber
2Swiss Tropical and Public Health Institute, Basel, Switzerland
3University of Basel, Basel, Switzerland
Elly Kourany-Lefoll
4Ares Trading S.A., Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany
Ali Ali
1Ifakara Health Institute, Dar es Salaam, Tanzania
Brooke Hayward
5EMD Serono, Inc. Rockland, MA, United States, an affiliate of Merck KGaA, Darmstadt, Germany
Deon Bezuidenhout
6Merck (Pty) Ltd, South Africa, an affiliate of Merck KGaA, Darmstadt, Germany
Wilhelmina Bagchus
7Merck Institute of Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany
Abdunoor M Kabanywanyi
1Ifakara Health Institute, Dar es Salaam, Tanzania

Article usage
Posted April 11, 2019.
Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: a randomized, single-blind, crossover study
Muhidin K Mahende, Eric Huber, Elly Kourany-Lefoll, Ali Ali, Brooke Hayward, Deon Bezuidenhout, Wilhelmina Bagchus, Abdunoor M Kabanywanyi, On behalf of the Pediatric Praziquantel Consortium
bioRxiv 605170; doi: https://doi.org/10.1101/605170
Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: a randomized, single-blind, crossover study
Muhidin K Mahende, Eric Huber, Elly Kourany-Lefoll, Ali Ali, Brooke Hayward, Deon Bezuidenhout, Wilhelmina Bagchus, Abdunoor M Kabanywanyi, On behalf of the Pediatric Praziquantel Consortium
bioRxiv 605170; doi: https://doi.org/10.1101/605170
Subject Area
Subject Areas
- Biochemistry (10379)
- Bioengineering (7695)
- Bioinformatics (26371)
- Biophysics (13547)
- Cancer Biology (10719)
- Cell Biology (15460)
- Clinical Trials (138)
- Developmental Biology (8509)
- Ecology (12842)
- Epidemiology (2067)
- Evolutionary Biology (16885)
- Genetics (11414)
- Genomics (15493)
- Immunology (10638)
- Microbiology (25254)
- Molecular Biology (10239)
- Neuroscience (54586)
- Paleontology (402)
- Pathology (1671)
- Pharmacology and Toxicology (2899)
- Physiology (4354)
- Plant Biology (9263)
- Synthetic Biology (2561)
- Systems Biology (6789)
- Zoology (1470)